Vimarsana
Biggest News Aggregation in the World

Medicine Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicine Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicine Study Today - Breaking & Trending Today

World News | US Senators Oppose Move to Reclassify Potato as a Grain - Vimarsana News

World News | US Senators Oppose Move to Reclassify Potato as a Grain

Get latest articles and stories on World at LatestLY. A powerful group of American Senators from both the Republican and Democratic parties have vehemently opposed the move to reclassify potato as a grain and asserted that it should be considered as a vegetable, which is the case right now. World News | US Senators Oppose Move to Reclassify Potato as a Grain.

Novocardia™ Cardiologist Co-Authors JAMA Study on Familial Idiopathic Dilated Cardiomyopathy - Vimarsana News

Novocardia™ Cardiologist Co-Authors JAMA Study on Familial Idiopathic Dilated Cardiomyopathy

/PRNewswire/ -- Novocardia, a value-based cardiovascular disease care platform, congratulates Dr. Javier Jimenez, an advanced heart failure and cardiac...

It's All Relative: How Much Dilated Cardiomyopathy Is Familial? - Vimarsana News

It's All Relative: How Much Dilated Cardiomyopathy Is Familial?

A large, multicenter cohort study supports phenotype-based screening of first-degree family members of patients with confirmed DCM without input, necessarily, from genetic testing.

DCM Screening Often Turns Up Familial Cases - Vimarsana News

DCM Screening Often Turns Up Familial Cases

Risk 89% higher for families of Black patients with dilated cardiomyopathy

Psilocybin News | Live Feed & Top Stories - Vimarsana News

Psilocybin News | Live Feed & Top Stories

Use at least 8 characters, an uppercase and a lowercase letter, and a number or symbol. Please ensure your password has at least 8 characters, an uppercase and a lowercase letter, and a number or symbol. By clicking 'Create Account and Subscribe' you agree to us creating an account for you and subscribing you to our newsletter in accordance with our Privacy Policy and Legal Notice. Emails, which may be sent daily or less frequently, may include marketing elements. We will not share your email address with any third parties. You can unsubscribe whenever you want. By clicking 'Sign in and Subsc...